Among the $ 160 billion value of drug patents which expire in 2015, antiboides will constitute a significant part. Global monoclonal antibody drug market will reach $ 62.8 billion by 2015, and some of the patents will also expire. Chinese companies such as CITIC Healthcare and Watson Biological Co. are expected to profit most.

China Bio news release, December 24, 2013